Related references
Note: Only part of the references are listed.Epigenetic control of oligodendrocyte development: adding new players to old keepers
Jia Liu et al.
CURRENT OPINION IN NEUROBIOLOGY (2016)
Clemastine Enhances Myelination in the Prefrontal Cortex and Rescues Behavioral Changes in Socially Isolated Mice
Jia Liu et al.
JOURNAL OF NEUROSCIENCE (2016)
Dynamic Modulation of Myelination in Response to Visual Stimuli Alters Optic Nerve Conduction Velocity
Ainhoa Etxeberria et al.
JOURNAL OF NEUROSCIENCE (2016)
Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination
Feng Mei et al.
JOURNAL OF NEUROSCIENCE (2016)
Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage
Sarah Moyon et al.
CELL REPORTS (2016)
Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination
Jayshree Samanta et al.
NATURE (2015)
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo
Fadi J. Najm et al.
NATURE (2015)
Update on Disease-Modifying Treatments for Multiple Sclerosis
Michael D. Carrithers
CLINICAL THERAPEUTICS (2014)
Adapting Brain Metabolism to Myelination and Long-Range Signal Transduction
Johannes Hirrlinger et al.
GLIA (2014)
A unified cell biological perspective on axon-myelin injury
Mikael Simons et al.
JOURNAL OF CELL BIOLOGY (2014)
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis
Feng Mei et al.
NATURE MEDICINE (2014)
Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains
Jimmy L. Huynh et al.
NATURE NEUROSCIENCE (2014)
Pervasive Axonal Transport Deficits in Multiple Sclerosis Models
Catherine Diamante Sorbara et al.
NEURON (2014)
Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons
Shailender Singh et al.
ACTA NEUROPATHOLOGICA (2013)
The role of myelin and oligodendrocytes in axonal energy metabolism
Aiman S. Saab et al.
CURRENT OPINION IN NEUROBIOLOGY (2013)
A regenerative approach to the treatment of multiple sclerosis
Vishal A. Deshmukh et al.
NATURE (2013)
A rapid and reproducible assay for modeling myelination by oligodendrocytes using engineered nanofibers
Seonok Lee et al.
NATURE PROTOCOLS (2013)
Oligodendrocyte Dynamics in the Healthy Adult CNS: Evidence for Myelin Remodeling
Kaylene M. Young et al.
NEURON (2013)
Oligodendroglia: metabolic supporters of axons
Brett M. Morrison et al.
TRENDS IN CELL BIOLOGY (2013)
Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation
Federica De Angelis et al.
DEVELOPMENTAL NEUROBIOLOGY (2012)
Axon degeneration: Molecular mechanisms of a self-destruction pathway
Jack T. Wang et al.
JOURNAL OF CELL BIOLOGY (2012)
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Youngjin Lee et al.
NATURE (2012)
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Ursula Fuenfschilling et al.
NATURE (2012)
Animal models of multiple sclerosis: the good, the bad and the bottom line
Richard M. Ransohoff
NATURE NEUROSCIENCE (2012)
Neuroprotection and repair in multiple sclerosis
Robin J. M. Franklin et al.
NATURE REVIEWS NEUROLOGY (2012)
Neurite outgrowth inhibitor Nogo-A establishes spatial segregation and extent of oligodendrocyte myelination
S. Y. Christin Chong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Age-dependent fate and lineage restriction of single NG2 cells
Xiaoqin Zhu et al.
DEVELOPMENT (2011)
Clemastine causes immune suppression through inhibition of extracellular signal-regulated kinase-dependent proinflammatory cytokines
Pal Johansen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
Ivana Nikic et al.
NATURE MEDICINE (2011)
Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination
Stephen P. J. Fancy et al.
NATURE NEUROSCIENCE (2011)
Regenerative medicine in multiple sclerosis: Identifying pharmacological targets of adult neural stem cell differentiation
Jeffrey K. Huang et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Presynaptic m1 muscarinic receptors are necessary for mGluR long-term depression in the hippocampus
Ariel Kamsler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease
E. C. Tallantyre et al.
BRAIN (2009)
Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Bruce D. Trapp et al.
LANCET NEUROLOGY (2009)
Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis
T. Kuhlmann et al.
BRAIN (2008)
Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies
Hans-Christian von Buedingen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Remyelination in the CNS: from biology to therapy
Robin J. M. Franklin et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Histamine receptor H1 is-required for TCR-mediated p38 MAPK activation and optimal IFN-γ production in mice
Rajkumar Noubade et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
A developmental switch in the response of DRG neurons to ETS transcription factor signaling
S Hippenmeyer et al.
PLOS BIOLOGY (2005)
Mechanisms of axon ensheathment and myelin growth
DL Sherman et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
C Lappe-Siefke et al.
NATURE GENETICS (2003)
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease
C Bjartmar et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Axonal degeneration and progressive neurologic disability in multiple sclerosis
C Bjartmar et al.
NEUROTOXICITY RESEARCH (2003)
Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time
T Kuhlmann et al.
BRAIN (2002)
Why does remyelination fail in multiple sclerosis?
RJM Franklin
NATURE REVIEWS NEUROSCIENCE (2002)
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis
A Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice
DJ Gerber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors
M Jutel et al.
NATURE (2001)
Pharmacological and functional characterization of muscarinic receptor subtypes in developing oligodendrocytes
F Ragheb et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Acute axonal injury in multiple sclerosis -: Correlation with demyelination and inflammation
A Bitsch et al.
BRAIN (2000)
Axonal changes in chronic demyelinated cervical spinal cord plaques
G Lovas et al.
BRAIN (2000)
Share Paper
